Elan Corp PLC (ELN)

[io_io]

Bapineuzumab for Glaucoma - one can speculate that Elan has already some clinical evidence based upon casual observations in the Phase I and Phase II trials.

http://www.pnas.org/cgi/reprint/0703707104v1

I will also later post a link to the Paper in the I-box above.